← Leaderboards
David Ian Quinn
University Of Southern California
$4,779,068
Attributed
$7,690,320
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $949K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$7,690,320 · 9
By mechanism
P30$3,025,178 · 1
U10$3,023,086 · 1
UG1$1,343,792 · 1
M01$298,264 · 6
Top collaborators
- Anthony Boutros El-Khoueiry8 shared
- Heinz Josef Lenz8 shared
Most similar at University Of Southern California
Same institution · by research overlap
- Caryn Lerman$95,133,528
- Heinz Josef Lenz$20,123,312
- Anthony Boutros El-Khoueiry$6,814,457
- Mariana C Stern$2,406,912
- Ite A Laird-Offringa$7,799,915
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelResourcesFundingClinical ResearchResearch ActivityClinical TrialsGrantAreaMalignant NeoplasmsResponseToxic EffectSafetyUsc/Norris Comprehensive Cancer Center And HospitalCancer CenterMedical CenterCountyLos AngelesDesignCholangiocarcinomaDrug DevelopmentData AcquisitionCancer TherapyBaseDedications
Grant awards (19)
NCTN - Network Lead Academic Participating Site: USC$409,376
UG1 · FY2021 · CA
NCTN - Network Lead Academic Participating Site: USC$464,856
UG1 · FY2020 · CA
NCTN - Network Lead Academic Participating Site: USC$469,560
UG1 · FY2019 · CA
NCI NCTN- Network Lead Academic Participating Site: USC$523,827
U10 · FY2018 · CA
NCI NCTN- Network Lead Academic Participating Site: USC$596,003
U10 · FY2017 · CA
NCI NCTN- Network Lead Academic Participating Site: USC$627,370
U10 · FY2016 · CA
NCI NCTN- Network Lead Academic Participating Site: USC$646,885
U10 · FY2015 · CA
NCI NCTN- Network Lead Academic Participating Site: USC$629,001
U10 · FY2014 · CA
Clinical Investigations Support Office$703,609
P30 · FY2010 · CA · contact PI
Clinical Investigations Support Office$713,631
P30 · FY2009 · CA · contact PI
A PHASE I/II STUDY OF E7389 HALICHONDRIN B ANALOG IN METASTATIC UROTHELIAL TR$194,793
M01 · FY2009 · RR · contact PI
A PHASE I STUDY OF VEGF- ANTISENSE OLIGONUCLEOTIDE (VEGF-AS) GIVEN AS A DAILY$40,583
M01 · FY2009 · RR · contact PI
Clinical Investigations Support Office$610,976
P30 · FY2008 · CA · contact PI
A PHASE I/II STUDY OF E7389 HALICHONDRIN B ANALOG IN METASTATIC UROTHELIAL TR$26,437
M01 · FY2008 · RR · contact PI
Clinical Investigations Support Office$687,042
P30 · FY2007 · CA · contact PI
A PHASE I/II STUDY OF E7389 HALICHONDRIN B ANALOG IN METASTATIC UROTHELIAL TR$21,320
M01 · FY2007 · RR · contact PI
Clinical Investigations Support Office$309,920
P30 · FY2006 · CA · contact PI
PROTOCOL FOR ASSESSMENT OF GEMCITABINE AND PACLITAXEL FOR METASTIC UROTHELIAL$13,064
M01 · FY2006 · RR · contact PI
PHASE II MULTI-CENTER TRIAL OF BAY 56-3722 (BAY 38-3441) IN PATIENTS WITH$2,067
M01 · FY2005 · RR